Evolve: The Latest GPU Benchmark Suite
Revolutionary tool redefines performance evaluation for the graphics industry BREDA, Netherlands, March 24, 2025 /PRNewswire/ — Traverse Research, one of the... Read more.
Fleet Team Welcomes Marc Terwilliger as Vice President of Warehouse Systems
Independence, Ohio, March 24, 2025 /PRNewswire/ — Fleet Team, a fleet management and consulting leader, is pleased to announce the appointment of Marc Terwilliger... Read more.
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS
BEIJING, March 24, 2025 /PRNewswire/ — SineuGene Therapeutics Co., Ltd. (“SineuGene”), a clinical-stage biotech company pioneering innovative... Read more.
Europe Becomes a New Strategic Hub for ChangAn Automobile’s “Vast Ocean Plan” as Global Growth Accelerates
Review of the Globalization Journey of the Vast Ocean Plan MUNICH, March 24, 2025 /PRNewswire/ — ChangAn Automobile (“ChangAn” or “the Company”),... Read more.
NextPlat Reports $65.5 Million in Consolidated Year-End 2024 Revenue
COCONUT GROVE, Fla., March 24, 2025 /PRNewswire/ — NextPlat Corp (NASDAQ: NXPL, NXPLW) (“NextPlat” or the “Company”), a global e-Commerce... Read more.
Blue Owl Capital Hires Robert Campkin as Part of European Net Lease Strategy
Robert brings nearly 30 years of commercial real estate experience along with deep corporate relationships across EMEA, Asia and North America. NEW YORK, March... Read more.
Hornetsecurity named Top Player in Radicati’s Secure Email – Market Quadrant 2025
Specialist email security and messaging analyst recognizes Hornetsecurity’s solid vision for the future PITTSBURGH, March 24, 2025 /PRNewswire/ — Hornetsecurity... Read more.
Caju AI Expands Microsoft Teams Integration to Unify Collaboration, Streamline External Communications, and Enforce Enterprise-Grade Compliance
CHARLOTTESVILLE, Va., March 24, 2025 /PRNewswire/ — Caju AI, a Microsoft Partner and leading innovator in Agentic AI-driven communications, security, and compliance,... Read more.
Pathios Therapeutics Appoints Sumeet Ambarkhane, M.D., as Chief Medical Officer
Appointment Aligns with Company’s Ongoing Maturation as Lead Cancer Program Progresses Through First-in-Human Study and Preclinical Activities for CNS Indications... Read more.
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
SAN JOSE, Calif., March 24, 2025 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology... Read more.